Credit: JANA SCHEFFOLD
AMANDA HOLSTAD SINGLETON IS THE LEAD AUTHOR IN A STUDY SHOWING HOW THE COMBINATION OF TWO NEW SUBSTANCES EFFECTIVELY KILLS MRSA. THE SUBSTANCES ARE WELL TOLERATED BY HUMAN CELLS, MAKING THEM A PROMISING CANDIDATE FOR A NEW ANTIBIOTIC.